| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |